|This message contains images. If you don't see images, click here to view.|
Advertise in this news brief.
PHARMACEUTICAL CAREER NEWS
Actavis CEO Expects Further Pharmaceutical Industry Consolidation
Actavis PLC Chief Executive Officer Brent Saunders said on Wednesday that the pharmaceutical industry will continue to consolidate because of inefficiencies in research and development and product commercialization.
"I think you will see a continued consolidation over the next several years," Saunders told analysts and investors at a meeting. Actavis is currently awaiting regulatory and other approvals for its purchase of Allergan Inc.
Four Tips To Making A Positive First Impression
By Anne Rose
Much has been written about executing amazing customer service, but let's focus today on one aspect that's immediately implementable: first impressions.
You've heard the axiom, "First impressions count." They do! So why do so many people pay so little attention to how they first greet or interact with a potential client? It takes a few seconds to properly impress a new client, and it takes days or weeks (or never) to undo a negative first impression.
Biomedical Research: Creating Jobs, Saving Lives
Morrow County Sentinel
Medical research not only creates jobs — it saves lives. But critical research — on cancer prevention, on new prescription drugs, and on cures for deadly diseases — is often left unfunded. In fact, nine out of 11 research grants go unfunded.
The National Institutes of Health, or NIH, represents the cornerstone of medical advancement in the United States. It is our nation’s largest funder of life sciences research and has a presence — both direct and indirect — in every state and nearly every congressional district.
Pharmaceutical Company Selects Iowa Site
Quad-City Business Journal
A company with 182 years in the health care and pharmaceutical industry is the firm behind the construction of a 340,000-square-foot warehouse and distribution center in Clear Lake.
Officials revealed that the “mystery company” behind the project is McKesson Corp. McKesson was founded in 1833 by John McKesson and Charles Olcott as a wholesale importer of therapeutic drugs and chemicals.
The warehouse-distribution center is under construction on two lots in the Larry Luker Memorial Industrial Park. The project is expected to create 164 new jobs with an average salary of $39,000.
Life Science Startups Rising in the UK
The Huffington Post
Stephen Chambers spent 22 years in some of the most innovative companies in life science as the director of gene expression and then as a co-founder of his own company. Today he runs SynbiCITE, the U.K.'s synthetic biology consortium of 56 industrial partners and 19 academic institutions, located at Imperial College in London.
Stephen and SynbiCITE just launched the world's first Lean LaunchPad for synthetic biology program.
Is This Job Candidate A Devil Or Angel?
By Mel Kleiman
It is human nature to prefer like-minded others who share our values, assessments and opinions, but it's in your best interest to curb this tendency when evaluating job candidates. Nothing could be a bigger hindrance to your organization's success than being fully staffed by cookie-cutter replicas of top management.
Think about it. Do your customers all think, look and act alike? Most certainly not. How are you going to "find a need and fill it," if no one on staff knows what that need might be?
Drug Company To Fill Vacant Building With 150 Jobs, $25M Investment
Cincinnati Business Courier
A Pennsylvania-based pharmaceutical company plans to open a manufacturing facility in Blue Ash, bringing 150 new jobs.
Aprecia Pharmaceuticals Co. will invest $25 million in an existing building at 10901 Kenwood Road to expand its manufacturing operations. The Ohio Tax Credit Authority approved a 55 percent, eight-year job creation tax credit on Monday morning for Aprecia Pharmaceuticals.
Trans-Pacific Partnership's Big Pharma Giveaway
The Trans-Pacific Partnership (TPP) trade deal is causing quite a stir around the world, and for good reason. There are multiple pro-corporate provisions within this massive trade deal that certainly merit being labeled “profit over people.” One of these is the Investor-State dispute settlement, which gives foreign corporations the ability to sue governments if a new law or regulation has effects on their profit rate; a blatantly pro-investor mechanism.
AAPS Career Services
Colby Horton, Vice President of Publishing, MultiBriefs, 469.420.2601
Download media kit
Jessica Taylor, Medical Editor, MultiBriefs, 202.684.7169
Be sure to add us to your address book or safe sender list so our emails get to your inbox. Learn how.
This edition of the AAPS Pharmaceutical Career News was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Feb. 13, 2015
Jan. 22, 2015
Jan. 9, 2015
Dec. 12, 2014
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063